Actualités et vidéos - PHIBRO ANIMAL HEALTH

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2023 financial results on Wednesday, August 30, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 31, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting http://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 27, 2023, to stockholders of record at the close of business on September 6, 2023. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers,...

Phibro Animal Health Corporation (Nasdaq: PAHC) is a global leader in animal health and mineral nutrition. We partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals. We provide solutions to help them maintain and enhance the health of their animals. We are proud to share our second Environmental, Social and Governance (ESG) Report (the “Report”). The Report highlights certain key performance indicators for the year ending...

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter and year-to-date ended March 31, 2023. Highlights for the three months ended March 31, 2023 (compared to the three months ended March 31, 2022) Net sales of $245.7 million, an increase of $6.1 million, or 3% Net income of $10.0 million, a decrease of $7.6 million, or 43% Diluted EPS of $0.25, a decrease of $0.19, or 43% Adjusted EBITDA of $27.4 million, a...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 28, 2023, to stockholders of record at the close of business on June 7, 2023. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers,...

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 3, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 4, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1...

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities 2023 Health Care Conference. Chief Financial Officer Damian Finio will address financial analysts and investors on Tuesday, May 9, 2023, at 4:20 PM PDT. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com . A replay of the session will be available and archived on the company’s website....

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Global Healthcare Conference. Chief Financial Officer Damian Finio will address financial analysts and investors on Thursday, March 15, 2023, at 10:45 AM ET at the Loews Miami Beach Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com . A replay of the session will be available and archived on the...

Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Bank of America 2023 Virtual Animal Health Summit. Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and investors on Thursday, March 2, 2023, at 10:50 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com . A replay of the...

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2022. Highlights for the three months ended December 31, 2022 (compared to the three months ended December 31, 2021) Net sales of $244.6 million, an increase of $11.9 million, or 5% Net income of $7.2 million, a decrease of $10.3 million, or 59% Diluted EPS of $0.18, a decrease of $0.25, or 59% Adjusted EBITDA of $30.9 million, an...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Alejandro Bernal, DVM, MS, MBA, as a Class III director of the Company, effective immediately. Mr. Bernal will be an independent director. His appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent directors. Mr. Bernal recently became Chief Executive Officer of PetDx® – The Liquid Biopsy Company for Pets™, a company based in...

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 8, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 9, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and...

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2022, and reiterated its financial guidance for Net sales and Adjusted EBITDA and revised its guidance for Net income, Diluted EPS, Adjusted net income, Adjusted diluted EPS and Adjusted effective tax rate for the year ending June 30, 2023. Highlights for the three months ended September 30, 2022 (compared to the three months ended...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 21, 2022, to stockholders of record at the close of business on November 30, 2022. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers,...

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its first quarter financial results on Wednesday, November 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 10, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and...

Phibro Animal Health Corporation (Nasdaq:PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided financial guidance for the year ending June 30, 2023. Highlights for the three months ended June 30, 2022 (compared to the three months ended June 30, 2021) Net sales of $255.3 million, an increase of $35.0 million, or 16% Net income of $7.5 million, a decrease of $9.6 million, or 56% Diluted EPS of $0.18, a...

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its fourth quarter and fiscal year 2022 financial results on Wednesday, August 24, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 25, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 28, 2022, to stockholders of record at the close of business on September 7, 2022. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers,...

Phibro Animal Health Corporation (Nasdaq:PAHC) and Rejuvenate Bio, Inc. today announced a collaboration for the development and commercialization of a gene therapy for Mitral Valve Disease (MVD) in canines (dogs). The incidence of MVD varies widely but is believed to be present in about 7% of all dogs and can be as high as 80% for some breeds such as Cavalier King Charles Spaniels. Rejuvenate Bio has received support from the American Cavalier King Charles Spaniel Club for this research. MVD is...

Phibro Animal Health Corporation (Nasdaq: PAHC), a diversified global developer, manufacturer, and supplier of a broad range of animal health and mineral nutrition products for livestock, published its inaugural Environmental, Social and Governance (ESG) Report (the “Report”). The Report establishes Phibro’s baseline on certain key performance indicators as of December 31, 2021, by providing disclosures containing relevant, industry-specific data and information aligned with the...